Aspartate β-Hydroxylase Serves as a Prognostic Biomarker for Neoadjuvant Chemotherapy in Gastric Cancer

Xuejun Gan(Peking University), Ziyu Li(Peking University)
International Journal of Molecular Sciences
March 13, 2023
10.3390/ijms24065482
Cited by 13

Related Papers

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
|The Lancet Oncology|2021|436
D-Limonene: Promising and Sustainable Natural Bioactive Compound
|Applied Sciences|2024|116
D-Limonene Inhibits Pichia kluyveri Y-11519 in Sichuan Pickles by Disrupting Metabolism
|Molecules|2024|4